The landscape of personalised medicine in the HR+ MBC space is constantly changing. Great summary at #ESMOAsia of how we incorporate biomarkers into our treatment sequencing.
Medical Oncologist & Breast Cancer Clinical Trials Fellow @ Peter Mac ➡️ Dana-Farber 2025. 🌈 #MedSky #OncSky #BCSM #WomenInMedicine